Pharmacogenomics of episodic migraine: time has come for a step forward.

about

The influence of genetic constitution on migraine drug responses.Variability of the characteristics of a migraine attack within patients.Association of RAMP1 rs7590387 with the risk of migraine transformation into medication overuse headache.

P2860

Q38949801-AF965C3A-24F4-416D-B0B3-37621343431B Q40396310-FDB676CF-F718-47C5-88CD-16087A4822EE Q48226245-DC2FD2AE-140A-4491-89D6-B8790ABB81F3

P2860

Pharmacogenomics of episodic migraine: time has come for a step forward.

Item

http://www.wikidata.org/entity/Q38195629

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pharmacogenomics of episodic migraine: time has come for a step forward.

@en

type

Item

label

Pharmacogenomics of episodic migraine: time has come for a step forward.

@en

prefLabel

Pharmacogenomics of episodic migraine: time has come for a step forward.

@en

P1476

Pharmacogenomics of episodic migraine: time has come for a step forward

@en

P2093

Cristina Tassorelli

http://www.w3.org/2001/XMLSchema#string

Francesco Pierelli

http://www.w3.org/2001/XMLSchema#string

Gaetano S Grieco

http://www.w3.org/2001/XMLSchema#string

Giuseppe Nappi

http://www.w3.org/2001/XMLSchema#string

Salvatore Terrazzino

http://www.w3.org/2001/XMLSchema#string

P2860

Genetics of migraine in the age of genome-wide association studies

Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society

Genetics of migraine and pharmacogenomics: some considerations

Migraine headache: a review of the molecular genetics of a common disorder

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force

Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study

The International Classification of Headache Disorders, 3rd edition (beta version)

Genome-wide association analysis identifies susceptibility loci for migraine without aura.

Italian guidelines for primary headaches: 2012 revised version

P304

541-549

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.14.20

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24624920

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics

migraine disorder

Pharmacogenomics of episodic migraine: time has come for a step forward.

about

P2860

P2860

Pharmacogenomics of episodic migraine: time has come for a step forward.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921